What is the appropriate treatment for tinea pedis of the heels in an elderly patient?

Treatment of Tinea Pedis to Heels in Elderly

For tinea pedis involving the heels (moccasin-type/hyperkeratotic tinea pedis) in elderly patients, oral terbinafine 250 mg once daily for 2-4 weeks is the preferred treatment, as topical therapy alone is often insufficient for this thick, hyperkeratotic presentation.

Why Oral Therapy is Preferred for Heel Involvement

Tinea pedis affecting the heels typically presents as the hyperkeratotic (moccasin-type) variant, characterized by thick scaling and hyperkeratosis that extends across the plantar surface and heels 1. This form is notoriously difficult to treat with topical agents alone because:

• The thick stratum corneum prevents adequate penetration of topical antifungals
• The causative organism (usually Trichophyton rubrum) is deeply embedded in the hyperkeratotic tissue
• Elderly patients may have difficulty applying topical medications to their feet

First-Line Treatment Recommendation

Oral terbinafine 250 mg once daily for 2-4 weeks is the optimal choice 2, 3:

• Efficacy: 86% mycological cure rate for moccasin-type tinea pedis 3
• Convenience: Once-daily dosing improves adherence in elderly patients
• Short duration: 2-week course is often sufficient, though 4 weeks may be needed for extensive disease
• Superior outcomes: Faster clinical resolution compared to topical therapy alone 2

Important Monitoring in Elderly Patients

Before initiating terbinafine in elderly patients:

• Check baseline liver function tests and complete blood count 4
• Screen for pre-existing liver disease (contraindication)
• Review medication list for potential drug interactions
• Assess renal function (dose adjustment may be needed in severe renal impairment)

Common pitfall: The most concerning adverse events are isolated neutropenia and rare liver failure, particularly in patients with pre-existing liver disease 2. While generally well-tolerated, elderly patients warrant closer monitoring.

Alternative Oral Options

If terbinafine is contraindicated or not tolerated:

Itraconazole 100 mg daily for 2-4 weeks 5, 6:

• Effective for both Trichophyton and Microsporum species
• Take with food for optimal absorption
• More drug interactions than terbinafine (especially with cardiac medications common in elderly)
• Monitor liver function tests

Fluconazole (off-label for tinea pedis):

• Less commonly used but can be considered
• Requires longer treatment duration

Role of Topical Therapy

Topical antifungals should be used as adjunctive therapy, not monotherapy for heel involvement 1:

• Terbinafine 1% cream once daily can be added to oral therapy
• Apply after mechanical debridement of hyperkeratotic tissue (if feasible)
• Continue for 1-2 weeks beyond clinical resolution
• Ciclopirox 0.77% cream twice daily is an alternative with 60% cure rates when used alone 2, but insufficient for thick heel lesions

Critical Adjunctive Measures for Elderly Patients

Address predisposing factors to prevent recurrence 7:

1. Treat concurrent conditions:

   • Tinea pedis between toes (interdigital type) - common reservoir
   • Onychomycosis (toenail fungus) - requires separate, longer treatment
   • Diabetes - increases risk and complicates healing 2, 8

2. Foot hygiene education 2, 8:

   • Daily foot washing and thorough drying, especially between toes
   • Daily sock changes (cotton, absorbent socks)
   • Avoid walking barefoot in communal areas
   • Discard or treat contaminated footwear 4

3. Manage edema and venous insufficiency 7:

   • Common in elderly patients
   • Increases recurrence risk
   • May require compression therapy

Treatment Algorithm

1. Confirm diagnosis (if possible): KOH preparation or fungal culture of heel scrapings 1
2. Initiate oral terbinafine 250 mg daily after checking baseline labs
3. Add topical terbinafine 1% cream to heels once daily
4. Mechanically debride hyperkeratotic tissue if patient can access podiatry
5. Treat any concurrent interdigital tinea pedis or onychomycosis
6. Continue treatment for 2-4 weeks (assess at 2 weeks; extend if needed)
7. Implement preventive foot care measures
8. Follow-up at 4-8 weeks post-treatment to confirm mycological cure

Special Considerations in Elderly

• Polypharmacy: Check for drug interactions, especially with warfarin, statins, and cardiac medications
• Cognitive impairment: Ensure caregiver involvement for medication adherence and foot care
• Mobility limitations: May need assistance with foot hygiene and topical application
• Diabetes prevalence: Screen for and optimize glycemic control 2
• Recurrence risk: Consider prophylactic antifungal powder in shoes after cure 2

Common pitfall: Treating with topical therapy alone for hyperkeratotic heel involvement leads to treatment failure. The thick scale prevents adequate drug penetration, necessitating systemic therapy.